KALARIS THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
KALARIS THERAPEUTICS, INC. (KLRS) reported Basic Shares Outstanding (Weighted Average) of 23.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 23.80M shares, a 27.25% increase year-over-year.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 23.72M shares, a 485.31% increase year-over-year.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 19.45M shares, a 1337.92% increase year-over-year.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 18.70M shares, a 1282.99% increase year-over-year.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 15.27M shares, a 1042.86% increase from fiscal 2024.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.34M shares, a 70.47% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 4.52M shares, a 94.10% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 76.65M shares, a 22.10% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 23.80M shares 10-Q · filed 2026-08-11 | 23.76M shares 10-Q · filed 2026-08-11 | 22.33M shares derived: average of 3 quarters · filed 2026-08-11 | 21.42M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 23.72M shares 10-Q · filed 2026-05-12 | 21.59M shares derived: average of 2 quarters · filed 2026-05-12 | 20.63M shares derived: average of 3 quarters · filed 2026-05-12 | 20.15M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 19.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 19.08M shares derived: average of 2 quarters · filed 2026-03-17 | 18.95M shares derived: average of 3 quarters · filed 2026-08-11 | 15.27M shares 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | 18.70M shares 10-Q · filed 2025-11-12 | 18.70M shares derived: average of 2 quarters · filed 2026-08-11 | 13.87M shares 10-Q · filed 2025-11-12 | 10.70M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 18.70M shares 10-Q · filed 2026-08-11 | 11.42M shares 10-Q · filed 2026-08-11 | 8.04M shares derived: average of 3 quarters · filed 2026-08-11 | 6.36M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 4.05M shares 10-Q · filed 2026-05-12 | 2.70M shares derived: average of 2 quarters · filed 2026-05-12 | 2.25M shares derived: average of 3 quarters · filed 2026-05-12 | 2.02M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 1.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 1.35M shares derived: average of 2 quarters · filed 2026-03-17 | 1.34M shares derived: average of 3 quarters · filed 2026-03-17 | 1.34M shares 10-K · filed 2026-03-17 | 5.01M shares 10-K · filed 2025-03-07 | |||
| 2024-09-30 | 1.35M shares 10-Q · filed 2025-11-12 | 115.40M shares 10-Q · filed 2024-11-12 | 1.34M shares derived: average of 2 quarters · filed 2025-11-12 | 1.33M shares 10-Q · filed 2025-11-12 | 115.07M shares 10-Q · filed 2024-11-12 | -69.99M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 1.33M shares 10-Q · filed 2025-08-13 | 115.13M shares 10-Q · filed 2024-08-09 | 1.32M shares 10-Q · filed 2025-08-13 | 114.91M shares 10-Q · filed 2024-08-09 | -93.77M shares derived: average of 3 quarters · filed 2025-08-13 | -41.86M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 1.31M shares 10-Q · filed 2025-05-14 | 114.69M shares 10-Q · filed 2024-05-13 | -141.32M shares derived: average of 2 quarters · filed 2025-05-14 | -56.25M shares derived: average of 3 quarters · filed 2025-05-14 | -18.53M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -283.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -85.03M shares derived: average of 2 quarters · filed 2025-03-07 | -25.14M shares derived: average of 3 quarters · filed 2025-03-07 | 4.52M shares 10-K · filed 2025-03-07 | 104.06M shares 10-K · filed 2024-03-15 | |||
| 2023-09-30 | 113.89M shares 10-Q · filed 2024-11-12 | 104.26M shares derived: average of 2 quarters · filed 2024-11-12 | 100.68M shares 10-Q · filed 2024-11-12 | 98.70M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 94.63M shares 10-Q · filed 2024-08-09 | 93.97M shares 10-Q · filed 2024-08-09 | 93.64M shares derived: average of 3 quarters · filed 2024-08-09 | 91.46M shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 93.30M shares 10-Q · filed 2024-05-13 | 93.14M shares derived: average of 2 quarters · filed 2024-05-13 | 90.41M shares derived: average of 3 quarters · filed 2024-05-13 | 83.92M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 92.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 88.96M shares derived: average of 2 quarters · filed 2024-03-15 | 80.80M shares derived: average of 3 quarters · filed 2024-03-15 | 76.65M shares 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | 84.95M shares 10-Q · filed 2023-11-02 | 74.71M shares derived: average of 2 quarters · filed 2023-11-02 | 71.21M shares 10-Q · filed 2023-11-02 | 69.19M shares derived: average of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | 64.47M shares 10-Q · filed 2023-08-03 | 64.23M shares 10-Q · filed 2023-08-03 | 63.94M shares derived: average of 3 quarters · filed 2023-08-03 | 63.70M shares derived: average of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | 63.99M shares 10-Q · filed 2023-05-04 | 63.68M shares derived: average of 2 quarters · filed 2023-05-04 | 63.44M shares derived: average of 3 quarters · filed 2023-05-04 | 63.17M shares derived: average of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | 63.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | 63.16M shares derived: average of 2 quarters · filed 2023-02-15 | 62.89M shares derived: average of 3 quarters · filed 2023-02-15 | 62.78M shares 10-K · filed 2023-02-15 | ||||
| 2021-09-30 | 62.96M shares 10-Q · filed 2022-11-03 | 62.65M shares derived: average of 2 quarters · filed 2022-11-03 | 62.59M shares 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | 62.34M shares 10-Q · filed 2022-08-04 | 62.40M shares 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |